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1. Introduction 
The thyroid nodules constitute an important diagnostic problem mainly because various 
benign lesions must be distinguished from malignant neoplasms. This problem is of 
particular importance in endemic and postendemic areas where there are a lot of patients 
with multiple thyroid nodules. In such areas the majority of thyroid lesions is non-
neoplastic and develop usually when diffuse goitre transforms into nodular one 
(Laurberg et al;. 2010, Słowińska-Klencka et al., 2002, 2008). Other non-neoplastic thyroid 
lesions may develop due to thyroiditis (acute thyroiditis, de Quervain disease, and 
autoimmune chronic thyroiditis). The frequency of revealing thyroid cancer – in 
comparison to malignancies in other organs – is relatively low. On the other hand, it is the 
most common cancer of endocrine glands, and the incidence of thyroid cancer is 
continuously increasing (Hughes et al., 2011; Sipos & Mazzaferri, 2010). This increase is 
partly related to the improvements to efficacy of preoperative diagnostics, but whatever is 
the nature of the observed higher incidence of the thyroid cancer it focuses the interests of 
physicians. It should be stressed that epidemiological assessments based on clinical data 
do not reflect the true incidence of the thyroid cancer, as it is found in as much as 30% of 
cadavers if the thyroid is serially examined during autopsy (Fukanaga & Yatani, 1975; 
Harach et al., 1985). In majority of such cases these cancers are subclinical papillary 
microcancers (with diameters below 10 mm) that are usually not diagnosed in alive 
patients. However, recently it has been shown that cytological examination of small 
thyroid lesions reveals invasive cancers (with the presence of cancer cells in lymph nodes 
and infiltration of the thyroid capsule) with a surprisingly high frequency (Chow et al. 
2003; Kang et al., 2004; E.K. Kim et al., 2002; Lin et al., 2005; Nam-Goong et al., 2004; 
Papini et al., 2002, Słowińska-Klencka et al., 2008).  
2. Influence of iodine supply on epidemiology of the thyroid lesions 
Thyroid nodules can be revealed by palpation in 4–7% of adult patients in the areas of 
sufficient iodine supply, and in 10–15% in the areas of mild to moderate iodine deficiency 
(Hegedűs 2004; Knudsen et al., 2000; Tunbridge et al., 1977). The use of ultrasound (US) 
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imaging raises ten times the rate of discovering thyroid lesions in comparison with 
palpatory examination (Ezzat et al., 1994; Tan et al., 1995). Many of these lesions do not 
exceed 10 mm in diameter. That increase poses diagnostic challenges particularly in 
endemic areas or areas with newly corrected iodine supply. We showed that, in such an 
area, focal lesions were found in the thyroid glands of nearly 80% of the examined patients, 
and the frequency of multinodular goitre, irrespective of the size of lesions, was 
considerably high – above 77%. Between infracentimetric nodules, found in more than 40% 
of all examined persons, the percentage of multiple lesions was even higher – above 80% 
(Słowińska-Klencka et al., 2008). This constitutes a major difference in comparison with 
countries with high iodine supply, where the thyroid lesions more frequently occur as single 
nodules (Feldt-Rasmussen, 2001; Frates et al. 2006; D.L. Kim 2008; E.K. Kim et al., 2002; 
Słowińska-Klencka et al., 2002). 
The differences in iodine supply influence also the incidence of various pathological lesions 
in the thyroid (Laurberg et al. 2010). In endemic areas patients with nodular goitre and 
follicular neoplasms predominate. The introduction of iodine prophylaxis is related to a 
gradual decline in the occurrence of non-neoplastic nodular goitre as well as of follicular 
neoplasms; on the other hand, papillary cancer is diagnosed more frequently (Feldt-
Rasmussen, 2001; Lind et al., 1998; Schmid 1989; Słowińska-Klencka et al., 2002; Solymosi et 
al., 2002). It should be remembered that the observed increase in the relative frequency of 
papillary carcinoma is partly attributed to the improving effectiveness of routine 
preoperative and postoperative morphological diagnostics that usually parallels 
introduction of iodine prophylaxis. It leads to more frequent revealing of papillary 
microcarcinoma and proper diagnosing of the follicular variant of papillary carcinoma 
without erroneous classification of such tumours into follicular carcinomas. The data from 
Sweden do not suggest any enhancing effect of iodisation on papillary carcinoma, since the 
increases in the incidence of such type of cancer were similar in both iodine-deficient and 
iodine-sufficient areas (Petteersson et al., 1996). Moreover, the correction of iodine 
deficiency rates virtually coincided in highly developed countries with the spread of thyroid 
ultrasound and biopsy, which have made diagnosis of clinically silent thyroid carcinoma 
more frequent. Thus, even though the incidence of thyroid carcinoma rose, the prognosis 
has significantly improved due to a shift towards differentiated forms of thyroid carcinomas 
that are diagnosed at earlier stages (Feldt-Rasmussen, 2001).  
On the other hand, countries with high iodine supply are characterised by higher 
incidence of the thyroid autoimmune diseases, and especially of chronic thyroiditis. Our 
studies, carried to monitor side-effects of the introduction of iodine prophylaxis in 
Poland, showed that the occurrence of autoimmune stigmata in thyroid cytological 
smears were gradually increasing as iodine prophylaxis became more effective (Fig. 1) 
(Słowińska-Klencka et al., 2002; 2006). Similar observations were reported in a study from 
Greece by Doufas et al., (1999) and from Argentina by Harach & Williams (1995) 
(although during much longer intervals before and after introduction of iodine 
prophylaxis). It is believed that iodine intake might modulate the activity (and/or clinical 
expression) of thyroid autoimmune diseases in genetically susceptible individuals, but 
there is no evident proof that the amount of iodine intake - at least when in the range 
between iodine deficiency and full physiological doses - is involved in the de novo 
triggering of thyroid autoimmunity.  
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Fig. 1. The occurrence of chronic thyroiditis in cytological results in years 1992-2010 in one 
diagnostics centre in Poland. House-hold salt iodization was initiated in early 90’s and in 
1997 obligatory model of iodine prophylaxis (30 mg KI/kg of salt) was introduced.  
3. Basic rules for diagnosing thyroid nodules 
The need for an effective differential diagnostics of focal lesions in the thyroid comes from 
the necessity of an early diagnosis of thyroid cancer that even as a small lesion may show 
extrathyoidal invasiveness. The basic examination used for that purpose is fine-needle 
aspiration biopsy (FNAB). During the past years, many reports have been published 
indicating the usefulness of FNAB in the diagnosis of thyroid nodules. Fine-needle 
aspiration biopsy is a quick and, at the same time, the most sensitive examination in 
diagnosing thyroid nodules. The main advantages of FNAB are: the possibility of selecting 
patients for prompt surgical treatment, low invasiveness, and relatively low cost of 
examination (Faquin et al. 2011; Gharib et al., 2010; Lewis et al. 2009; Seningen et al., 2011). 
The management of thyroid nodule is usually based on cytological result which should 
always be interpreted together with other clinical data, mainly those related to the risk of 
cancer in the nodule. The clinical indications of the increased risk of cancer include: 
presence of hard painless nodule with diminished mobility (especially if the nodule causes 
hoarseness, dysphagia or dyspnoea), quick growth of the lesion as well as enlargement of 
the lymph nodes in the neck (Gharib et al., 2010; Wada et al., 2003). There are also other 
features of some importance in clinical suspicion of malignancy in a nodule: male sex, 
patient’s age below 15-20 or above 60-70, history positive for neck irradiation or prolonged 
hyperstimulation of the thyroid with TSH (Belfiore et al., 1992; Hegedűs 2004; Kumar et al.; 
1999; Samann et al., 1987; Schneider & Sarne, 2005). Familial history of thyroid cancer is of 
particular importance in relation to medullary cancer (MTC) as well as papillary cancer 
(PTC) (Kloos et al., 2009; Nose, 2011; Stoffer et al., 1986). The diagnosis of chronic thyroiditis 
is also of importance as it is considered to facilitate development of lymphoma of the 
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thyroid. Some investigators also believe that chronic thyroiditis is related to higher risk of 
papillary cancer (Azizi et al., 2011; Boi et al., 2005; Gul et al., 2010; Mukasa et al., 2011; 
Ruggiero et al., 2005; Shih et al., 2008; Singh et al., 1999; Słowińska-Klencka et al., 2006). 
For proper interpretation of cytological smears it is also necessary to analyse the thyroid 
function and possible antithyroid treatment, as well as other laboratory results (like 
calcitonin serum concentration). Imaging examinations and oncological history (with 
possible chemo- and radiotherapy) should also be considered (Słowińska-Klencka et al., 
Gharib et al, 2010).  
4. Role of ultrasound imaging in diagnostics of thyroid nodules 
The thyroid ultrasonography (US) is the most common imaging examination of the gland. It 
allows to determine the precise size of the thyroid and to reveal non-palpable focal lesions. 
Despite of this, according to endocrine societies (American Thyroid Association – ATA, 
American Association of Clinical Endocrinologists – AACE and European Thyroid 
Association – ETA) guidelines, US is not recommended as a screening examination for 
patients without clinical data for the increased risk of cancer or clinical suspicion for any 
thyroid disease (Gharib et al, 2010).  
Until recently, US was used in Europe more frequently than in the United States, and 
similarly US was more commonly used in Europe as a support to FNAB (Bennedbæk, 1999; 
Bennedbæk & Hegedűs 2000; Bonnema et al., 2000, 2002). At present it is proved that US 
assistance improves the diagnostic efficiency of FNAB in relation to both small and large, 
palpable lesions (Cesur et al., 2006). US allows to detect features suggestive of malignant 
growth and select the lesions to be recommended for FNAB. It also makes it possible to 
select the area of lesion optimal for FNAB (i.e. solid part free of areas of necrosis) and to 
choose the right gauge and length of the biopsy needle (Gharib et al., 2010). Because of its 
low invasiveness and possibility of multiple repeating in a patient, US is also useful for the 
assessment of goitre treatment effectiveness (both surgical and conservative) (Quadbeck et 
al., 2002). US examination is also used for diagnosing developmental disorders of the 
thyroid. In the cases of thyroid malignancy it allows to assess the completeness of 
thyroidectomy and the presence of possible local recurrence, as well as to control local 
lymph nodes (Frasoldati et al., 2003; Gharib et al., 2010; Hegedűs, 2001; Rago et al., 1998; 
Wong & Ahuja, 2005). It should be stressed that US does not allow by itself to differentiate 
between benign and malignant thyroid lesions (Gharib et al., 2010; Hegedűs, 2001). 
4.1 Role of ultrasound imaging in selection of thyroid lesions for FNAB – A new 
approach  
The precise indications for FNAB of thyroid lesions are still being investigated. The main 
criteria considered include sonographic features of nodules like the size, shape and 
echogenicity of lesions, the vascular pattern in Doppler imaging, the presence of 
microcalcifications and appearance of lesion’s borders (Alexander et al., 2004; Frates et al., 
2005; Gharib et al., 2010; Nam-Goong et al., 2004; Papini et al., 2002; 12–16; Tae et al., 2007). 
Current recommendations on the diagnostics of thyroid nodules take into consideration the 
similar frequency of revealing thyroid cancer  in FNAB of small vs. large nodules (Berker et 
al., 2008; Nam-Goong et al., 2004; Papini et al., 2002), palpable vs. non-palpable nodules 
(Papini et al., 2002; Popowicz et al., 2009; Hagag et al., 1998) as well as solitary vs. multiple 
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nodules (Belfiore et al., 1992; Frates et al., 2006). In consequence, the recommendations focus 
on US features related to the increased risk of malignancy, and not on the size nor 
palpability of the nodule, which were important criteria in the previous recommendations.  
Interestingly, attention is paid to US features allowing to identify invasive cancers including 
those growing in very small lesions. Some recent papers have brought convincing data on 
the high percentage of carcinomas (some of them with extrathyroidal invasion) in small 
lesions subjected to FNAB (Kang et al., 2004; E.K. Kim et al., 2002; S.J. Kim et al., 2003; 
Leenhardt et al., 1999; Lin et al., 2005; Nam-Goong et al., 2004; Papini et al., 2002). The 
majority of these reports come from the countries with natural high iodine supply (Japan, 
Korea) or those with long-established iodine prophylaxis. However, our data from the post-
endemic region confirm these observations. In our material, the frequency of revealed small 
and large cancers was proportional to the frequency of the biopsied nodules of each size 
class, and approx. 1/3 of cytologically revealed thyroid microcancers metastasized to lymph 
nodes (Słowińska-Klencka et al., 2008).  
Analysis of the reported studies justifies division of the known US features suggestive of 
malignancy into 2 groups of high and low specificity. 
The highly specific US features in selection of thyroid lesions for FNAB include: 
1. features of metastasis in the lymph nodes; 
2. features of the thyroid capsule (or neighbouring organs) invasion;  
3. microcalcifications (small, intranodular, punctate, hyperechoic spots with scanty or no 
posterior acoustic shadowing).  
The features of lower specificity include: 
1. irregular or microlobulated margins; 
2. more tall (anteroposterior) than wide (transverse) shape; 
3. marked hypoechogenicity; 
4. chaotic arrangement or intranodular vascular images. 
It should be stressed that the assessment of these features is yet not enough standardized, 
and because of their qualitative or semi-quantitative nature their reproducibility is not 
satisfactory (especially when sonographer lacks experience).  
According to our observations and some other studies, there are differences in sensitivity 
and specificity of these features in respect of nodule size (Popowicz et al., 2008; Mazzaferri 
& Sipos, 2008). The influence of epidemiological situation (mainly iodine supply) on the 
specificity and sensitivity of these features is also underestimated.  
The most sensitive feature of malignancy is hypoechogenicity, both for small and large 
lesions. Unfortunately, the specificity of this feature is low, especially in small nodules – 
majority of benign lesions (especially the small ones) is hypoechoic (Moon et al., 2008; 
Cappelli et al., 2006, 2007; Chan et al., 2003; Frates et al., 2005; 2006; E.K. Kim et al., 2002; 
Leenhardt et al., 1999; Lyshchik et al., 2005; Nam-Goong et al., 2004; Papini et al., 2002). 
Interestingly, in our material, all invasive microcarcinomas (with the signs of extrathyroidal 
growth or with spread to lymph nodes) were hypoechoic in the US examination (Popowicz 
et al., 2009). The role of hypoechogenicity, in revealing aggressive variants of 
microcarcinomas, was also indicated by Barbaro et al. (2005).  
The most specific single feature is the presence of microcalcifications in the lesion (Cappelli 
et al., 2006, 2007; Chan et al., 2003; Frates et al., 2005, 2006; Iannuccilli et al., 2004; E.K. Kim et 
al., 2002; Moon et al., 2008; Nam-Goong et al., 2004; Papini et al., 2002; Rago et al., 2007). It 
increases tenfold the risk of cancer, but the sensitivity of this feature is low, particularly in 
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group of nodules not exceeding 10 mm (Popowicz et al., 2009). Similar results were obtained 
by Moon et al., (2008).  
Less but still significantly predictive is the shape index (Alexander et al., 2004; Berker et al., 
2008; Cappelli et al., 2006; E.K. Kim et al., 2002; Moon et al., 2008). Our analysis shows that 
the features describing the shape of lesion are useful mainly in the diagnostics of small 
nodules (Popowicz et al., 2009). Similar results with respect to the ratio of long to short axis 
of a lesion were reported by Berker et al. (Berker et al., 2008). The shape of larger lesions is a 
less sensitive feature probably because such lesions are more frequently partially cystic, and 
as such are more spherical even if benign.  
With respect to the assessment of blood flow pattern, the published opinions are 
contradictory with some reporting that Doppler US is helpful (Papini et al., 2002; Moon et 
al., 2008; Cappelli et al., 2007; Chan et al., 2003; Lyshchik et al., 2005; Levine, 2006), and 
others reporting that Doppler US did not satisfactory improve diagnostic accuracy (Nam-
Goong et al., 2004; Frates et al., 2003; Iannuccilli et al., 2004; Rago et al., 1998). Even though 
the logistic analysis of regression allows classification of intranodular vascular pattern as an 
independent feature suggesting malignancy, the OR is several times lower than for other 
features (Cappelli et al., 2007). 
It is difficult to apprehend the role of lesion’s borders assessment because there are 
significant differences in the definition of suspected appearance of borders. Some 
researchers, such as Nam-Gong et al., (2004), suggested that ill-defined nodules were 
important for predicting malignancies, while others (E.K. Kim et al., 2002, Cappelli et al., 
2006, 2007 and Kang et al., 2004) suggested that irregular margins were important. 
Moreover, some authors reported that the presence of blurred margins was not significantly 
linked to malignancy of lesions (Leenhardt et al., 1999; Frates et al., 2006; Iannuccilli et al., 
2004), or that well-defined margins were a common sonographic feature in papillary 
carcinomas (Chan et al., 2003). 
Up to now, any single criterion of selecting lesions for FNAB was not found to be 
satisfactory. The analysis of usefulness of feature combinations brought diverse results, both 
in terms of specificity and sensitivity of such a set of features, and the possible reduction in 
the number of performed FNABs. This reduction is of particular importance in endemic 
areas where it determines economic effectiveness of cytological examination. Because of 
high predominance of benign thyroid lesions in such areas, the number of performed 
FNABs is very high in relation to the number of revealed cancers. 
The current recommendations try to relate the indications for FNAB to predictive value of 
particular features and the size of lesion: the lower predictive value of a feature, the larger 
lesion that should be selected for FNAB (Gharib et al., 2010). However, in the setting of 
endemic goitre it is very difficult, if not impossible, to follow the recommendation to 
examine all solid hypoechoic lesions of diameter above 1 cm. Large number of such lesions 
makes their further selection a must. Thus it is important to underline the role of US 
examination in prioritization of lesions. In the cases of multiple thyroid nodules it is 
advisable to biopsy those lesions which are positive for a highly specific feature and those 
positive for several features of lower value.  
The available recommendations suggest the number of lesions that should be biopsied in order 
to satisfactory exclude the risk of malignancy in the multiple nodular goitre (according to 
ATA/AACE/ETA – 2 lesions, and according to Polish recommendations, relating to 
postendemic area - 3-4 lesions) (Gharib et al., 2010; Sporny et al., 2010). However, such 
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suggestions are the results of experts’ consensus. There are few studies addressing this issue 
(Frates et al. 2006), and the mean number of lesions in goitre to be examined differs significantly 
between iodine rich and iodine deficient areas. Anyway it is justified to subject lesions to FNAB 
in the order resulting from the predictive value and number of positive US features. 
In this context it should be mentioned that current recommendations indicate also negative 
features, i.e. those which allow to resign from biopsy. It is justified not to perform FNAB in 
the cases of purely cystic nodules, spongiform nodules, or autonomic nodules in patient 
with low TSH levels (Bonavita et al., 2009; Gharib et al., 2010). 
The current recommendations underline the necessity of proper selection of the area within 
examined lesions that should be biopsied. In the case of cystic-solid lesions it is indicated to 
biopsy the solid part and to evaluate any fluid evacuated from the cystic part. Our 
experience shows that the use of cytological centrifuge for preparation of fluid significantly 
lowers the percentage of non-diagnostic outcomes (Słowińska-Klencka et al. 2004). In the 
case of solid lesions the biopsy of central part should be avoided as there is higher 
probability of necrosis in that area. In the case of large nodules it is recommended to 
perform at least 2 aspirations from various areas of the lesion.  
4.2 Role of ultrasound imaging in diagnostics of thyroid lesions of size < 5 mm 
The current recommendations distinguish the category of lesions of diameter below 5 mm. It 
is indicated to monitor such lesions with US examinations including the evaluation of 
features that can be helpful in revealing invasive microcancers or in making decision of 
FNAB. Such recommendation is based on several rationales: lower accuracy of US features 
evaluation in such small lesions, higher probability of missing lesion during aspiration 
(especially in dorsal location of lesion), and lower clinical aggressiveness of cancers smaller 
than 5 mm (Mazzaferri & Sipos, 2008). Obviously, there are exceptions related to particular 
indications for FNAB including: extrathyroidal growth of nodule (extracapsular invasion, 
lymph nodes involvement or metastases); positive history of neck irradiation in childhood 
or adolescence; papillary thyroid cancers, medullary thyroid cancers, or multiple endocrine 
neoplasia type 2 in first-degree relatives; previous thyroid surgery for cancer; increased 
calcitonin levels in the absence of interfering factors (Berker et al., 2008; Mazzaferri & Sipos, 
2008; D.W. Kim et al., 2009; Kwak et al., 2008). Among features suggestive of the increased 
risk of invasive papillary cancer in lesion there are: shaping of the thyroid capsule by lesion 
or lesion abutting the capsule, and features of the lymph nodes involvement (Kwak et al., 
2008; Ito & Miyauchi, 2009). It should be stressed that predictive value of the latter is very 
diverse, and the highest specificity is found for the presence of calcifications or cystic 
degeneration (relating to areas of necrosis) in the lymph nodes (Leboulleux et al., 2007; 
Sipos, 2009). Some investigators suggest that such data from US examination may be also 
useful in the selection of optimal treatment strategy, and according to Ito et al., (2003, 2009) 
careful US examinations of patients with small nodules may even allow refraining from 
surgical treatment in some cases of papillary microcancers. However, such management is 
not recommended by ATA, AACE nor ETA. 
5. Efficacy of FNAB of thyroid nodules in the areas of various iodine supply  
The above mentioned differences between areas of various iodine supply in the incidence of 
thyroid nodules, their solitary and multiple occurrence, as well as distribution of particular 
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pathological lesions, significantly affect the efficacy of preoperative diagnoses of thyroid 
nodules.  
Our group performed one of few studies on the effectiveness of FNAB of thyroid nodules in 
areas with newly corrected iodine supply. It was a retrospective analysis of US examination 
and FNAB on a large series of thyroid glands, performed in a single diagnostic centre. The 
analysis included the outcomes of FNABs performed in years 1985-2010, and obligatory 
iodine prophylaxis using household salt iodized with 30 mg KI/kg was established in 
Poland in 1997. Earlier, iodine prophylaxis was carried out with numerous discontinuations 
from 1930s until 1980, when it was dropped. In the years 1992–1993, a nationwide study 
performed in about 20 000 schoolchildren, showed that Poland was an area of mild or 
moderate iodine deficiency (Szybiński & įarnecki, 1993). About this time salt iodization was 
partially reintroduced and iodine supply gradually increased. Reevaluation of iodine status 
of Polish population in early 2000s proved the efficacy of iodine prophylaxis by showing 
normalization of ioduria, rapid decrease in the incidence of goitre in schoolchildren and 
lowering the percentage of newborns with transient hyperthyrotropinemia (TSH> 5 mU/L) 
(Szybiński et al., 2008). 
In total nearly 40,000 FNAB results were analysed, and in more than 6000 patients those 
results were verified by histopathological examination. It was found that in endemic areas 
the number of performed FNABs was very high in relation to the number of revealed 
cancers, despite of adhering to the recommendations for selection of lesions for FNAB. This 
is a consequence of high incidence of multiple mostly benign lesions. As a result, the 
frequency of outcomes in the category of benign lesions is higher than in iodine-rich areas. 
The suspicious or malignant lesions constitute < 10% of all cytological results (Słowińska-
Klencka et al., 2002, 2008) while in areas of a long-term normal iodine supply this 
percentage reaches 20–30% (D.L. Kim et al., 2008; Nam-Goong et al., 2004). Moreover, in 
endemic or post-endemic areas the rate of malignant lesions in post-operative 
histopathological examination is relatively low. In our material, such rate was only 7% while 
in areas of high iodine supply it is several times higher. This difference results from a high 
number of patients in iodine-deficient areas who are referred to a surgeon not because of the 
suspicious FNAB outcome – only about 20% of the patients in our series – but because of 
large multinodular goitre, notwithstanding the benign outcome of FNAB (Słowińska-
Klencka et al., 2008).  
5.1 Efficacy of selection of thyroid nodules for FNAB in areas of various iodine supply  
In endemic areas it is more difficult to select lesions that should be biopsied, and the 
probability of wrong selection affects especially small lesions. Small nodules are usually 
accompanied by other, often larger lesions, which are more frequently chosen for FNAB. As 
a result, the efficacy of preoperative diagnoses of small carcinomas in endemic areas is 
significantly lower than in the case of larger malignant tumours (Popowicz et al., 2009; 
Słowińska-Klencka et al., 2008). These differences are deepened by the fact that in the areas 
of iodine sufficiency the reported percentages of false negative (FN) results are falsely 
lowered, as FNAB outcomes are frequently verified not against histopathological 
examination but clinical follow-up. In such areas patients with cytologically diagnosed 
benign lesions, without goitre are not usually surgically treated, and as a result there may be 
some misdiagnosed cases of thyroid microcarcinomas in that group of patients (Theoharis et 
al., 2009). In endemic areas many patients are subjected to thyroidectomy because of large 
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multinodular goitre and then some microcancers are revealed in lesions that were not 
selected for FNAB nor even identified in US examination. 
In respect to described differences, in the regions of a high number of patients with 
multinodular goitre, it seems reasonable to use more powerful and rigorous criteria for 
selecting lesions for FNAB. Such criteria should allow to optimize the number of performed 
FNABs in relation to the number of revealed cancers and, in particular, should allow to 
diagnose invasive cancers. Our study showed that some indolent cancers, which probably 
never become aggressive, were revealed, but some invasive microcancers were missed 
(Popowicz et al., 2009; Słowińska-Klencka et al., 2008). It could be helpful to use the more 
specific set of features for diagnosing invasive thyroid carcinoma but an optimal definition 
of such a set is still being sought. E.K. Kim et al., (2002) reported that reduction number of 
performed FNABs by 47%, with 94% sensitivity and 66% specificity, could be achieved by 
selecting lesions fulfilling the shape criterion or those with microcalcifications, irregular or 
microlobulated margins or marked hypoechogenicity (relative to the strap muscles in the 
neck). Those data come from areas of high-iodine supply and low incidence of multinodular 
goitre. In our material from the area of recently corrected iodine supply, it was found that 
similar reduction in the number of performed FNABs is possible on the condition of 
exclusion of hypoechogenicity from the set of selection criteria. Examination of lesions more 
tall than wide only, or those with microcalcification or solitary ones, would allow limitation 
of the number of biopsies by 50% while keeping sensitivity above 80%. However, it would 
increase the risk of misdiagnosing small invasive thyroid cancers (in our material all 
invasive small cancers were hypoechoic) (Popowicz et al., 2009). It is possible that 
application of ‘marked hypoechogenicity’ feature would allow avoidance of that risk. In our 
material the achieving of above 90% sensitivity in the group of small lesions (<10 mm) was 
possible if all hypoechoic nodules or those with suspected shape were selected for FNAB. 
Such selection could lower the number of performed biopsies by 28%. The addition of all 
solitary nodules and all nodules with microcalcifications would not increase the number of 
examinations significantly, but would allow for biopsying 98% of malignant lesions 
(Popowicz et al., 2009). Similar results were reported by other authors who used the 
selection criteria as the shape of lesions jointly with other features from the US examination 
as the selection criteria. Cappelli et al., (2006) showed that 99% sensitivity can be achieved 
by aspiration of lesions more tall than wide and possessing at least two of the following 
features: hypoechogenicity, blurred margins and calcifications. The authors claimed that by 
applying such criteria, the number of performed FNABs could be lowered by 28%.  
Most diagnostic algorithms suggest performing FNAB for solid, hypoechoic lesions with 
diameters over 10 mm, even in the absence of any other features suggesting the increased 
risk of cancer (Baloch et al., 2008; Gharib et al., 2010; Layfield et al., 2010). But in the case of 
large multinodular goitre, it is necessary to select large lesions for biopsy as well. Our 
studies showed that in the case of large nodules, the usefulness of sonographic features in 
selecting lesions for FNAB was less satisfactory than in the case of small ones. The 
sensitivity of selection of nearly 84% could be achieved by biopsying all hypoechoic or 
containing microcalcifications nodules or with the positive shape index, which would lower 
the number of FNAB by more than 55% (Popowicz et al., 2009).  
It is also worth mentioning that in the majority of the reports, the influence of nodule size on 
the optimal set of features for selecting lesions for FNAB was not investigated. Only 
Cappelli et al., (2006) observed that the associations of US features with malignancy were 
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similar in groups of large and small lesions. On the other hand, Lyshchik et al., (2005) and 
Berker et al., (2008) found that the usefulness of sonographic features in selecting lesions for 
FNAB in the group of larger nodules was lower than in the group of smaller ones, and that 
for thyroid nodules larger than 15 mm (Lyshchik) or than 10 mm (Berker) the only reliable 
criterion of cancer was hypoechogenicity. Moon et al., (2008) reported that a set of US 
features suggestive of malignancy (i.e. the presence of at least one of the findings including 
taller than wide shape, speculated margin, hypoechogenicity and the presence of 
calcifications) showed lower sensitivity and higher specificity for nodules >10 mm than for 
smaller nodules, which is in concordance with our data. 
The discussed epidemiological differences may also attribute to the observed differences in 
the frequency of obtaining non-diagnostic material from small lesions. The data on the 
efficacy of FNAB in obtaining diagnostic cellular material from small thyroid lesions are 
equivocal. Some reports suggest that the smaller the size of aspirated lesion the higher the 
rate of inadequate specimens (Cesur et al., 2006; Lee et al., 2006; Sahin et al., 2006). Other 
reports from Japan and Korea suggest that if the staff performing FNAB of the thyroid is 
experienced enough, it is possible to aspirate reliably even very small lesions – with 
diameters of 2–3 mm (D.W. Kim, et al., 2009; Nam-Goong et al., 2004; Yang et al., 2002). In 
these Asian countries, specialists more often diagnose very small thyroid lesions which – 
because of the specific epidemiological situation – less frequently coexist with other larger 
lesions but are microcarcinomas more frequently than in the countries with low iodine 
supply. 
5.2 Influence of iodine status of population on clinical interpretation of cytological 
results  
The proper selection of lesions for biopsy is one of the important components influencing 
the effectiveness of this examination. Another is an epidemiological situation of examined 
populations which affects the incidences of follicular lesions (follicular adenomas and 
carcinomas as well as hyperplastic nodules in nodular goitre) and papillary cancers (Feldt-
Rasmussen, 2001; Słowińska-Klencka et al., 2002).  
FNAB does not allow for differentiation among certain forms of nodular goitre, follicular 
adenoma, follicular carcinoma and frequently also follicular variant of papillary carcinoma 
of the thyroid. This problem is the main limitation of FNAB diagnostics, especially in 
endemic regions. Consequently, in clinical practice, the cytological diagnoses of ‘follicular 
neoplasm’ and, especially, of ‘Hürthle cell tumour’ are frequently regarded as an indication 
for surgical treatment. However in the areas of long-term iodine deficiency, the 
consideration of ‘follicular neoplasms’ results as an indicator of malignancy yields a 
significant increase in false positive results. In our material, in which ‘follicular neoplasm’ 
corresponds more frequently to non-neoplastic hyperplastic nodules or follicular adenoma 
than to thyroid cancers, such interpretation puts false positive results in range 10-12% 
(Słowińska-Klencka et al., 2002, 2008). This is the reason for low positive predictive value of 
FNAB in such areas. In iodine-rich areas ‘follicular neoplasm’ diagnosis corresponds more 
frequently to follicular variant of papillary cancer. 
Follicular cancer constituted 30% of all malignant tumours found in postoperative 
histopathological examination in patients who underwent FNAB at our centre before 
introduction of salt iodization, while 10 years later that percentage dropped to 6-7%. Parallel 
decrease in frequency of follicular adenoma was also observed. Papillary cancer constituted 
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about 45% of all malignant tumours in the first period and 75% in the second one 
(Słowińska-Klencka et al., 2002, 2008). Such marked changes over relatively short time may 
be attributed not only to the increased iodine supply but also to erroneous classification of 
follicular variant of papillary cancer in the earlier period. As it was already mentioned, an 
introduction of iodine prophylaxis is often accompanied by the increased interest in the 
thyroid diseases what improves the standards of histopathological examination.   
Analysis of the cytological results in our centre over the discussed period showed the 
gradual decrease in frequency of cytological results, applying to ‘follicular neoplasm”, while 
the frequency of diagnoses of oxyphilic variant of those neoplasms remained nearly 
constant (Fig. 2). 
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Fig. 2. The occurrence of cytological diagnoses of follicular neoplasm and Hürthle cell 
tumour 
Interestingly, in the analysed period the risk of revealing cancer in postoperative 
histopathological examination in nodules diagnosed cytologically as ‘follicular neoplasm’ 
dropped from above 15% to below 8%. Those lesions more frequently were found to be 
hyperplastic nodules in histopathological examination. The decrease in occurrence of 
cancers in lesions with cytological diagnosis of ‘follicular neoplasm’ was more pronounced 
than the decrease in frequency of formulating this cytological diagnosis (Słowińska-Klencka 
et al., 2002, 2008). It should be kept in mind that such lowering of the risk of cancer is 
transient. In regions of recently established iodine prophylaxis the risk of thyroid cancer in a 
lesion described in FNAB as ‘follicular neoplasm’ is lower than in regions of constant 
sufficient iodine supply, where thyroid nodules are rarer but more frequently malignant 
(Baloch et al., 2002; Mihai et al., 2009).  
Our data also show that if ‘follicular neoplasm’ in cytological outcome was assumed as a 
negative result with respect to cancer diagnosis it would cause a twofold increase in the 
number of undiagnosed cancers >10 mm and only 15% increase in the case of 
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infracentimetric cancers. Thus, it seems that in the regions of recently normalized iodine 
supply, in patients with such cytological outcome the surgical treatment may be postponed 
only in the case of small lesions (Słowińska-Klencka et al., 2008).  
Other reports also show that the size of lesion is important feature in the assessment of 
probability of thyroid cancer in patients with cytological diagnosis of follicular neoplasm. 
Lubitz et al., (2010), Mihai et al., 2009; Schlinkert et al., (1997) and Tutle et al., (1998) indicate 
that the size above 4 cm is significant; Baloch et al., (2002) - above 3 cm. 
Concluding, it is reasonable to individualize indications for surgical treatment – particularly 
in countries with similar to Polish epidemiological situation, where the risk of cancer in 
lesion diagnosed as ‘follicular neoplasm’ is relatively low (<10%). It seems that in such cases 
small lesions can be treated conservatively providing the strict clinical follow-up is assured 
with US monitoring. It should be stressed that even in such areas the risk of cancer in the 
case of cytological diagnosis of ‘Hürthle cell neoplasm’ is high and reaches 20-30% 
(Słowińska-Klencka et al., 2002). The similar data on the difference in the risk of cancer 
between cytologically diagnosed follicular and oxyphilic neoplasms were reported by 
Sangalli et al., (2006) and Baloch et al., (2002). Thus, in our opinion, if FNAB outcome 
suggests ‘Hürthle cell tumour’ indications for surgical treatment are stronger.  On the other 
hand, Pu et al., (2006), Sorrenti et al., (2009) and Theoharis et al., 2009 found no difference 
between such lesions regarding the rate of malignancy. However, Sorrenti et al., (2009) 
correctly mentions that more aggressive cancers tend to occur in patients with ‘Hürthle cell 
neoplasm’ than in persons with ‘follicular neoplasm’ diagnosed cytologically. 
5.3 New classification of thyroid FNAB results - the impact on frequency of particular 
diagnoses from follicular lesions in postendemic area 
The most recent recommendations for diagnostics of thyroid nodules permit centres with 
specific experience in thyroid cytology to divide diagnoses of follicular lesions into 
‘follicular lesion of undetermined significance’ and ‘follicular neoplasm’ categories 
(Baloch et al., 2008; Gharib et al., 2010; Layfield et al., 2010). This distinction separates 2 
cytologic groups at different risk for thyroid malignancy. At our centre similar distinction 
was introduced earlier – in some cases the cytopathologist tried to determine more 
precisely the benign character of the lesion by formulating the result as ‘follicular 
neoplasm – probably adenoma’ (Słowińska-Klencka et al., 2002). However, the current 
guidelines of National Institute of Cancer (NCI) assume wider definition of this particular 
diagnostic category. According to NCI ‘follicular lesion of undetermined significance’ is a 
heterogeneous category, which reflects the difficulty in the cytological diagnosis of the 
follicular lesions of the thyroid. It includes cases in which the cytomorphological findings 
are not representative of a benign lesion such as a hyperplastic ⁄ adenomatoid nodule, yet 
the degree of cellular or architectural atypia is not sufficient to render an interpretation of 
follicular neoplasm ⁄ suspicious for a follicular neoplasm or suspicious for malignancy. 
This diagnosis may also be used in thyroid FNAB specimens that are less than optimal 
due to limited cellularity, poor fixation and obscuring blood (Baloch et al., 2008; Layfield 
et al., 2010). The main reason for using this diagnostic category was to recommend a 
repeated FNAB in 3-12 months for these cases rather than surgical excision. The 
correlation of FNAB outcomes with the results of subsequent US examinations, or radio-
nucleotide uptake studies may be helpful in improving the positive predictive value of 
that ‘indeterminate’ category. 
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We assessed the influence of the application of new classification of the thyroid cytological 
outcomes in postendemic area in respect to follicular lesions from which monomorphic 
thyroid follicular cells (tfc) (comprising oxyphilic cells) arranged in three-dimensional 
groups including microfollicles were aspirated. The analysis covered 2 periods: year 2009 
and the period between May 2010 and February 2011. In the later period new classification 
of thyroid FNAB outcomes was used that was based on NCI classification with exclusion of 
cases with low cellularity from “follicular lesion of undetermined significance” subgroup. It 
was found that in both examined periods incidence of aspirates with monomorphic tfc was 
similar: 4.5% and 4.4% respectively. However the introduction of the subcategory of 
”follicular lesion of undetermined significance” significantly decreased the percentage of 
FNAB outcomes without diagnostic conclusion (p<0.0001, chi2 test) (Table 1). Thus, it seems 
that the introduction of this new category of FNAB results makes it easier for 
endocrinologists to choose proper therapeutic options, especially in postendemic areas. 
 
2009 V 2010 - II 2011 
Cytological results No/% Cytological results No/% 
Monomorphic tfc without 
conclusion 
168/72.1% 
Monomorphic tfc without 
conclusion - usually low 
cellularity smears 
66/30.4% 
Benign follicular nodule 10/4.3% Benign follicular nodule 4/1.8% 
Follicular neoplasm probably 
benign 
6/2.6% 
Follicular lesion of 
undetermined significance 
106/48.9% 
Follicular neoplasm 21/9.0% 
Suspicious for a follicular 
neoplasm 
21/9.7% 
Follicular neoplasm Hürthle 
cell type probably benign 
0/0.0% 
Follicular lesion of 
undetermined significance 
Hürthle cell type 
3/1.4% 
Follicular neoplasm Hürthle 
cell type 
28/12.0% 
Suspicious for a follicular 
neoplasm Hürthle cell type 
17/7.8% 
Number of follicular lesions 233/100.0% Number of follicular lesions 217/100.0% 
Table 1. Comparison of cytological outcomes from thyroid nodules, where monomorphic tfc 
dominated in aspirates, formulated in 2 periods: year 2009 and between May 2010 and 
February 2011. In the later period new classification of thyroid FNAB outcomes was used. 
Also Theoharis et al., (2009) found that the new approach of reporting thyroid FNA 
proposed by the NCI is advantageous in patients who may harbor a follicular or Hürthle cell 
neoplasm as it allows the reporting cytopathologists to express their level of concern of the 
possibility of an underlying malignancy to guide subsequent patient management. 
5.4 Increased incidence of Hashimoto disease in endemic areas and the risk of FNAB 
false results 
As it was already mentioned, the increase in iodine supply in endemic area  is related to the 
increase in the incidence of chronic thyroiditis. It significantly affects the efficacy of 
morphological diagnostics of the thyroid. Noticeable anisocytosis of follicular cells observed in 
some cases of chronic thyroiditis can lead to an increased number of false positive (FP) results 
of FNAB. Additionally, marked hypoechogenecity and heterogeneity of the thyroid in US 
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scans poses difficulties in revealing any focal lesions. Another important issue is a coincidence 
of papillary cancer and chronic thyroiditis, which is indicated by numerous investigators, and 
makes cytological diagnostics of patients with Hashimoto disease even more challenging 
(Azizi et al., 2011; Cipolla et al., 2005; Gul et al., 2010; Liu et al., 2001; Mukasa et al., 2011; 
Ruggiero et al., 2005; Shih et al., 2008; Singh et al., 1999; Słowińska-Klencka et al., 2006). 
In our material the frequency of papillary carcinoma diagnosed in postoperative 
histopathological examination was higher in the group of patients with cytologically 
confirmed chronic thyroiditis than in the group of patients with non-inflammatory benign 
lesion found in FANB (Słowińska-Klencka et al., 2006). There are also reports indicating the 
relation between the increased titres of antithyroid antibodies and the increased probability 
of obtaining FANB outcome which suggests or confirms thyroid malignancy (Boi et al., 
2005). It was also shown that the risk of thyroid cancers is positively correlated to TSH levels 
even in its normal range (Boelaert et al., 2006, 2009), and chronic thyroiditis is main reason 
for the increase of TSH levels. Even without judging whether chronic thyroiditis facilitates 
the growth of papillary cancer, or rather lymphocytic infiltration is a kind of response to 
growing tumour, it can be concluded that patients with Hashimoto disease should be 
followed-up with a particular attention (Gul et al., 2010; Okayasu et al., 1995). It should be 
also kept in mind that chronic thyroiditis is regarded as a risk factor for malignant 
lymphoma of the thyroid (Holm et al., 1985; Matsuzuka et al., 1995).  
5.5 Differences in statistical approach to the evaluation of FNAB efficacy 
The differences described above in epidemiological situations of examined populations 
result in significant  differences in the reported data on FP and false negative (FN) results, as 
well as sensitivity (from 65 to 98%) and specificity (from 72 to 100%) of the thyroid FNAB 
(Gharib et al., 2010). Another important source of these differences comes from the statistical 
approaches to the evaluation of FNAB data, which vary among authors, thus making the 
reported results hardly comparable (Słowińska-Klencka et al., 2002). Some authors exclude 
the so-called intermediate results (differently defined) from statistical analysis, while others 
exclude only the specific cases (e.g. exclusion from FP result, cases corresponding to 
follicular adenoma in histopathological examination or exclusion from FN results cases of 
papillary microcarcionomas incidentally found in postoperative histopathological 
examination ) (Cap et al., 1999; La Rosa  et al., 1991). This problem is further discussed in the 
papers by Lewis et al., (2009) and Theoharis et al., (2009). 
There is a general agreement that in regions of endemic goitre (with an increased incidence 
of follicular neoplasms), a high number of FP results should be accepted and negative 
results should be optimised (Papanicolaou Society of Cytopathology, 1996). FN results may 
delay the institution of appropriate treatment. On the other hand, it should be kept in mind 
that the real rate of FN results of FNAB could be masked by the relatively high percentage 
of patients with cytologically diagnosed benign lesions who are not surgically treated, while 
differentiated carcinoma need not progress for years. 
6. Rules of monitoring benign lesions – Its efficacy in relation to iodine 
supply 
Cytological diagnosis of benign lesion is related to very low risk of malignancy (1–2% in the 
case of US-guided FNAB), on condition that such diagnosis is formulated only if smears 
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satisfy strict quality criteria (Gharib et al., 2010). Assuming that these criteria were followed 
and the aspirated material was obtained from the examined lesion, there is no need to repeat 
FNAB unless changes in US image or other clinical data suggest the otherwise. It should be 
remembered that clinical decisions based on such cytological diagnosis should be limited to 
that particular lesion, and cannot be extended on other lesions. In the presence of any 
doubts it is justified to repeat FNAB after 6-12 months especially in lesions presenting some 
US features suggestive of malignancy (Kwak et al., 2010).  
Opponents against performing control FNABs even in the cases of non-progressing nodule, 
indicate that such examination usually does not significantly change the cytological category 
of examined lesion, it lowers economic efficiency of thyroid diagnostics, and it unnecessarily 
stimulates the fear of cancer in patient (Aguilar et al., 1998; Lucas et al.; 1995; Merchant et 
al., 2000). On the other hand, there are proponents of control FNABs, who indicate that 1-3 
control FNABs lower the risk of false negative results related to missing examined lesion 
(particularly small or dorsally located) (Flanagan et al., 2006; Gabalec et al., 2009; 
Hamburger 1987; Illouz et al. 2007; Orlandi et al. 2005). Some investigators suggest to 
perform follow-up FNA only in a selected group of patients with clinically suspicious 
symptoms (Chehade et al., 2001; Erdogan et al., 1998; Oertel et. al., 2007; van Roosmalen et 
al., 2010).  
Analysis of our material showed that performing one control FNAB increases diagnostic 
efficacy of cytological examination in respect to diagnosing cancer. Next control FNABs do 
not change the cytological category of examined lesion if no US/clinical signs of progression 
are observed (Słowińska-Klencka et al., 2001). In the case of very long follow-up (10 years or 
more), it seems less rational to limit the number of performed FNABs to 1 or 2, but there are 
no recommendations addressing this question.  
If quality criteria of smears are not satisfied FNAB should be classified as non-diagnostic. 
With such cytological outcome decision on surgical treatment must be based on the presence 
of clinical features suggesting the increased risk of cancer. If conservative treatment is 
undertaken, next biopsy should be performed within 3-12 months. Interpretation of non-
diagnostic biopsy should include clinical context as some thyroid diseases are related to 
difficulties in obtaining material satisfying all quality criteria (e.g. chronic thyroiditis, colloid 
nodule). If two subsequent examinations give non-diagnostic material then an individual 
clinical assessment of the risk of cancer in the evaluated lesion should be performed. It 
seems that solid lesions should be more readily treated surgically while mixed, cystic-solid 
lesions may be observed (with possibility of surgical treatment in future). According to 
British Thyroid Association [BTA] (2007) guidelines, clinical attention should be increased if 
there are blood cells and histiocytes in smear and thyroid follicular cells are absent. BTA 
advises to regard such smears as more suspicious than those without follicular cells but with 
dominating colloid. According to our data, the frequency of histopathologically diagnosed 
neoplasms (both malignant and benign) in solid lesions is higher in the case of lesions from 
which non-diagnostic material was obtained twice in comparison with lesions that showed 
diagnostic material in the repeated (second) FNAB. No similar difference was noted in 
relation to malignant neoplasms only. However, the risk of diagnosing cancer in 
postoperative examination was higher than in lesions with diagnostic cytological outcome 
(classified as benign) – about 7% vs. 2%, respectively (Słowińska-Klencka et al., 2004). 
Others reported similar data (Orija et al., 2007). There is a general agreement that ‘pure 
cystic’ lesions should be treated conservatively because of low risk of malignancy. 
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Additional difficulty in areas of iodine deficiency is related to follow-up of multiple thyroid 
nodules which can be easily misidentified in control ultrasound examinations. As 
indications for FNAB are based on US features of revealed lesions, it is very important to 
clearly describe in US report as many identified lesions as possible, with precise description 
of their location, size and features used for selection to FNAB. The US report should not be 
limited to the description of a dominant lesion, and report of US-guided FNAB should allow 
to identify biopsied lesion in other diagnostic centre (Gharib et al., 2010). It is advisable to 
attach to FNAB result the US report with description of lesions that have been biopsied. 
Such joined report allows to compare US features of lesions during control examination. 
This is particularly important in endemic areas where it may be difficult to identify lesion 
among many others in multiple nodular goitre.  
7. Conclusions  
In the endemic areas the typical ultrasound criteria for selection of lesions for FNAB are 
inefficient. The number of performed FNABs is very high in relation to the number of 
revealed cancers, but in spite of this, some invasive cancers are missed. On the other hand, 
some indolent cancers, which probably never become aggressive, are revealed. In the 
regions of a high number of patients with multinodular goitre, it seems reasonable to use 
more powerful and rigorous criteria for selecting lesions for FNAB that would allow to 
improve diagnostic and economic effectiveness of biopsy. Such criteria must include 
features with higher predictive value instead of or along with features with high sensitivity 
but low specificity (like nodule hypoechogenecity).  
In iodine-deficient areas in order to increase the chances of early detection of small invasive 
cancers, it seems particularly reasonable to follow up small lesions revealed in the thyroid 
with repeated US examinations. That allows detection of any significant changes in lesion 
image and lesion relationship with the thyroid capsule as well as evaluation of lymph nodes 
in the neck.  
While clinically interpreting the results of cytological examination, the iodine status of 
examined population should be considered. Changes in the iodine status of a given 
population promptly influence the clinical significance of particular cytological results. In 
such circumstances, special attention is advised from both the cytologist and the 
thyroidologist.  
Concluding, the clinical management of thyroid nodules in areas of high, sufficient or 
inadequate iodine supply is not fully comparable.  
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